Article Details
Retrieved on: 2022-04-04 17:02:26
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Goldman Sachs analyst Amit Hazan downgrades Baxter Intl (NYSE:BAX) from Neutral to Sell and lowers the price target from $88 to $77.
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here